Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|January 9, 2004
Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907]J M Witkin, D Dijkstra, B Levant, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer diseaseN C Bodick, W W Offen, H E Shannon, et al.
European Journal of Pharmacology|February 23, 1993
Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferensH E Shannon, B D Sawyer, K G Bemis, et al.
The Journal of Urology|January 1, 1996
Detrusor regeneration in the rat using porcine small intestinal submucosal grafts: functional innervation and receptor expressionJ D Vaught, B P Kropp, B D Sawyer, et al.
General Pharmacology|May 14, 1999
Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aortaB D Sawyer, F P Bymaster, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.
Neuropharmacology|September 6, 2002
Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptorA-M Linden, B G Johnson, S C Peters, et al.
Journal of Veterinary Pharmacology and Therapeutics|November 10, 2007
Development and validation of the maximal electro-shock seizure model in dogsP R Territo, K J Freise, K Newhall, et al.
Life Sciences|June 8, 2001
Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout miceF P Bymaster, P A Carter, L Zhang, et al.
Journal of Medicinal Chemistry|October 30, 1992
Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophoreJ S Ward, L Merritt, V J Klimkowski, et al.
Pageof 10